Resource

 

 

 

 

 

 

 

 

 

 

 

Arnold & Porter Advises Novartis on Licensing Agreement with Spark Therapeutics

12 Feb 2018

Arnold & Porter advised long-time client Novartis on its recent licensing agreement with Spark Therapeutics. The licensing agreement covers development, registration and commercialization rights to voretigene neparvovec in markets outside the US. Voretigene neparvovec, known as Luxturna in the US, received FDA approval on December 19, 2017 as a one-time gene therapy to restore functional vision in children and adult patients with biallelic mutations of the RPE65 gene. Currently there is no existing therapy for this disease outside the US.

Severgroup acquires controlling share in the capital of AVA-Peter Ltd

12 Feb 2018

Baker McKenzie represented Severgroup, a company managing investments on behalf of Mr. Alexey Mordashov, in connection with the acquisition of a controlling share in the capital of AVA-Peter Ltd., the owner of the “AVA-Peter” and “Scandinavia” clinics.
 
The Baker McKenzie team was led by Moscow partner Sergey Krokhalev with key input from associates Robert Gray, Igor Kungurov, Fedor Mukhodanov and Roman Ishmukhametov.
 

McDermott Advises Bank Consortium on Capital Increase of ProCredit Holding

12 Feb 2018

International law firm McDermott Will & Emery advised a bank consortium consisting of Joh. Berenberg, Gossler & Co. KG und equinet Bank AG on a capital increase of ProCredit Holding AG & Co KGaA. 5,354,408 newly issued shares were placed with qualified investors by way of an accelerated book-building process at a price of EUR 11.40 per new share, resulting in gross proceeds of approx. EUR 61 million. The company’s shares are traded on the Prime Standard segment of the Frankfurt Stock Exchange.

$20 Billion Restructuring of Oi S.A.

12 Feb 2018

Davis Polk is advising a major creditor and backstop party in the $20 billion restructuring of Brazilian telecommunications provider Oi S.A. Oi’s Recuperação Judicial (a proceeding under Brazil’s bankruptcy law) is the largest court-supervised restructuring ever to take place in Latin America. In addition to the proceedings in Brazil, Oi is also subject to chapter 15 cases in the United States and ancillary proceedings in other foreign jurisdictions.

Banco Safra $500 Million Notes Offering

12 Feb 2018

Davis Polk advised the dealers in connection with a Rule 144A and Regulation S offering by Banco Safra S.A., acting through its Cayman Islands Branch of $500 million aggregate principal amount of 4.125% senior notes due 2023 under Banco Safra’s medium-term notes program.

Banco Safra is a leading multiple bank ranked as the fourth-largest privately-owned bank in terms of total assets in Brazil.

Davis Polk Advises Nordic Capital on Its Proposed Acquisition of Nordax

12 Feb 2018

Davis Polk is advising Nordic Capital on a public cash offer to the shareholders of Nordax Group AB to acquire all outstanding shares for SEK 60 per share. The board of directors of Nordax unanimously recommended the offer.

Nordic Capital is a private equity investor in the Nordic region with a commitment to creating stronger, sustainable businesses through operational improvement and transformative growth. Nordax is a niche bank in Northern Europe, providing unsecured consumer loans and deposits to customers in Sweden, Norway, Finland and Germany.

Katten Represents IMF Bentham in $57 Million Portfolio Sale

12 Feb 2018

Katten represented IMF Bentham Ltd, an international litigation funding company, in the sale of the majority of its US investment portfolio to Bentham IMF Fund 1 LLC for $57.4 million. This transaction should serve to bolster the fund's investment portfolio while reducing risk and converting assets to cash for IMF Bentham. The fund was announced last year as a special purpose vehicle funded in part by Fortress Credit Advisors LLC. The Katten team featured Allison Yacker, New York Financial Services co-chair, and Rong Zhao, an associate in the firm's Chicago office.